KL-A167 Injection in Recurrent or Metastatic Nasopharyngeal Carcinoma
Clinical trial NCT03848286 · COMPLETED
Trial details
- NCT number
- NCT03848286
- Sponsor
- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-06
- Primary completion
- 2021-07-13
- Enrollment
- 153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.